Literature DB >> 22903278

Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family.

L-C L Tsai1, J A Beavo.   

Abstract

The main function of cyclic AMP phosphodiesterases (PDEs) is to degrade cAMP, a ubiquitous second messenger. Therefore, PDEs can function as prime regulators of cAMP/PKA-dependent processes such as steroidogenesis. Until recently, the roles of the PDE8 family have been largely unexplored, presumably due to the lack of a selective inhibitor. This review focuses on recent reports about the regulatory roles of the PDE8 family in adrenal steroidogenesis, as well as the inhibitory properties and specificity of a new PDE8-selective inhibitor, PF-04957325. We also describe a method of measuring urinary corticosterone levels in vivo as a minimally invasive way of monitoring the stress level in a mouse. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903278      PMCID: PMC4020523          DOI: 10.1055/s-0032-1321861

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  37 in total

1.  Angiotensin II activates cholesterol ester hydrolase in bovine adrenal glomerulosa cells through phosphorylation mediated by p42/p44 mitogen-activated protein kinase.

Authors:  Nadia Cherradi; Bruno Pardo; Andrew S Greenberg; Fredric B Kraemer; Alessandro M Capponi
Journal:  Endocrinology       Date:  2003-07-31       Impact factor: 4.736

2.  Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases.

Authors:  S H Soderling; S J Bayuga; J A Beavo
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

Review 3.  Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH.

Authors:  E R Simpson; M R Waterman
Journal:  Annu Rev Physiol       Date:  1988       Impact factor: 19.318

4.  Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution.

Authors:  P Wang; P Wu; R W Egan; M M Billah
Journal:  Gene       Date:  2001-12-12       Impact factor: 3.688

5.  cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis.

Authors:  Masami Shimizu-Albergine; Li-Chun Lisa Tsai; Enrico Patrucco; Joseph A Beavo
Journal:  Mol Pharmacol       Date:  2012-01-09       Impact factor: 4.436

Review 6.  Role of the hypothalamic pituitary adrenal axis in the control of the response to stress and infection.

Authors:  S M McCann; J Antunes-Rodrigues; C R Franci; J A Anselmo-Franci; S Karanth; V Rettori
Journal:  Braz J Med Biol Res       Date:  2000-10       Impact factor: 2.590

7.  Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain.

Authors:  Tamaki Kobayashi; Michiko Gamanuma; Takashi Sasaki; Yoko Yamashita; Keizo Yuasa; Jun Kotera; Kenji Omori
Journal:  Gene       Date:  2003-11-13       Impact factor: 3.688

8.  Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands.

Authors:  I J Davis; L F Lau
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

Review 9.  Adrenocortical zonation and ACTH.

Authors:  G P Vinson
Journal:  Microsc Res Tech       Date:  2003-06-15       Impact factor: 2.769

Review 10.  ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex.

Authors:  Marion B Sewer; Michael R Waterman
Journal:  Microsc Res Tech       Date:  2003-06-15       Impact factor: 2.769

View more
  12 in total

Review 1.  Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?

Authors:  Dominic Ngima Nthenge-Ngumbau; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

Review 2.  Phosphodiesterases and adrenal Cushing in mice and humans.

Authors:  E Szarek; C A Stratakis
Journal:  Horm Metab Res       Date:  2014-09-18       Impact factor: 2.936

Review 3.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

4.  Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation.

Authors:  Giulia Vigone; Leia C Shuhaibar; Jeremy R Egbert; Tracy F Uliasz; Matthew A Movsesian; Laurinda A Jaffe
Journal:  Endocrinology       Date:  2018-05-01       Impact factor: 4.736

5.  Antenatal glucocorticoid exposure enhances the inhibition of adrenal steroidogenesis by leptin in a sex-specific fashion.

Authors:  Yixin Su; Luke C Carey; James C Rose; Victor M Pulgar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-30       Impact factor: 4.310

6.  Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshop.

Authors:  C A Stratakis
Journal:  Horm Metab Res       Date:  2012-09-05       Impact factor: 2.936

7.  PDE8 Is Expressed in Human Airway Smooth Muscle and Selectively Regulates cAMP Signaling by β2-Adrenergic Receptors and Adenylyl Cyclase 6.

Authors:  Timothy B Johnstone; Kaitlyn H Smith; Cynthia J Koziol-White; Fengying Li; Austin G Kazarian; Maia L Corpuz; Maya Shumyatcher; Frederick J Ehlert; Blanca E Himes; Reynold A Panettieri; Rennolds S Ostrom
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 7.748

8.  Exposure to an Extremely-Low-Frequency Magnetic Field Stimulates Adrenal Steroidogenesis via Inhibition of Phosphodiesterase Activity in a Mouse Adrenal Cell Line.

Authors:  Kazuyoshi Kitaoka; Shiyori Kawata; Tomohiro Yoshida; Fumiya Kadoriku; Mitsuo Kitamura
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

9.  Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation.

Authors:  Amanda G Vang; Chaitali Basole; Hongli Dong; Rebecca K Nguyen; William Housley; Linda Guernsey; Alexander J Adami; Roger S Thrall; Robert B Clark; Paul M Epstein; Stefan Brocke
Journal:  Front Pharmacol       Date:  2016-08-23       Impact factor: 5.810

10.  Development of Phosphodiesterase-Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity.

Authors:  Nikhil K Tulsian; Valerie Jia-En Sin; Hwee-Ling Koh; Ganesh S Anand
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.